Family · Pharmaceutical analytical standards
Rufinamide
An antiepileptic approved in Europe in 2007 and in the United States in 2008 as add-on therapy for seizures in Lennox-Gastaut syndrome, a rare and severe form of epilepsy that begins in childhood. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It is a triazole derivative carrying two fluorine atoms: it binds to sodium channels in nerve cells and keeps them from switching to their active state, damping down abnormal electrical discharges.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
